Signal
What human evidence tends to support
Human data quality varies by indication and extract. Registry evidence tier: low. Use the evidence score on this page as a directional read, not a substitute for systematic reviews for your specific question.
Context
Where claims often outrun the trials
Marketing and influencer stacks often outpace replicated human outcomes for this category.
Retail framing
What products usually promise
Retail copy for GLA often generalizes mechanisms or pilot outcomes. Compare any “clinically proven” language to primary endpoints, population, and dose.
Our verdict label
Not enough quality human research to justify confident conclusions - treat bold promises skeptically.
Same ingredient, other questions
Focused pages for common searches about GLA (gamma-linolenic acid from EPO/borage). Each uses the same underlying evidence file with a different lens.
Explore further
A few hand-picked entry points around GLA (gamma-linolenic acid from EPO/borage): categories, answers to narrow questions, and comparisons.
Related ingredients
Ingredients we group near GLA (gamma-linolenic acid from EPO/borage) in our model - not interchangeable, but often read together.
- Psyllium husk78/100Strong support
Soluble fiber with strong evidence for constipation and as a lipid adjunct in some guideline discussions when taken with water.
- Omega-3 fatty acids77/100Promising
EPA/DHA support cardiovascular risk reduction contexts in some guidelines; supplements vary widely in quality and dose.
- Prebiotics76/100Strong support
Fibers and oligosaccharides that selectively feed commensal microbes; strongest human stories sit in IBS-style and regularity contexts.
Alternatives
Swaps people discuss alongside GLA (gamma-linolenic acid from EPO/borage) - still judge each ingredient on its own evidence.